Skip to content

EBIT at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$17.43M+85.6%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-$4.67M-319%
Mannkind logo
MannkindMNKD
-$1.67M-107%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
-$24.27M-30.2%
Insulet logo
InsuletPODD
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s EBIT?
Embecta Corp. (EMBC) reported EBIT of $35M in Q1 2026.
How has Embecta Corp.'s EBIT changed year-over-year?
Embecta Corp.'s EBIT decreased by 44.4% year-over-year, from $62.9M to $35M.
What is the long-term trend for Embecta Corp.'s EBIT?
Over 4 years (2021 to 2025), Embecta Corp.'s EBIT has grown at a -16.2% compound annual growth rate (CAGR), from $492M to $242.1M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.